Please enable JavaScript to continue using this application.

Compare $FHTX vs $UNCY | Chartloom

Compare

$FHTX vs $UNCY

Foghorn Therapeutics Inc · Unicycive Therapeutics Inc

FHTX

Foghorn Therapeutics Inc

UNCY

Unicycive Therapeutics Inc

Compare $FHTX vs $UNCY

Comparing Foghorn Therapeutics Inc and Unicycive Therapeutics Inc

FHTXFoghorn Therapeutics Inc

UNCYUnicycive Therapeutics Inc

FHTXFoghorn Therapeutics Inc

Market cap

$117M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.04x

Rev growth (TTM)

52.0%

YTD performance

-61.5%

52W performance

-55.6%

FCF yield

-71.8%

UNCYUnicycive Therapeutics Inc

Market cap

$110M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.31x

Rev growth (TTM)

—

YTD performance

-29.1%

52W performance

-13.8%

FCF yield

-25.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FHTX

UNCY

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

FHTX$117M

UNCY$110M

Enterprise Value

FHTX$49M

UNCY$66M

Price

FHTX$2.00

UNCY$4.11

P/E Ratio

FHTXN/A

UNCYN/A

P/S Ratio

FHTX3.20x

UNCY31.15x

EV/Sales

FHTX1.34x

UNCY0.00x

EV/EBITDA

FHTX0.00x

UNCY0.00x

P/B Ratio

FHTX1,199.58x

UNCY2.21x

P/FCF Ratio

FHTXN/A

UNCYN/A

EV/FCF

FHTX-0.59x

UNCY-2.35x

PEG Ratio

FHTXN/A

UNCYN/A

Forward P/E (NTM)

FHTXN/A

UNCYN/A

Forward P/S (NTM)

FHTX4.04x

UNCY0.31x

Revenue (TTM)

FHTX$37M

UNCY$0

Revenue Growth (YoY)

FHTX52.0%

UNCYN/A

Forward Rev Growth

FHTX7.3%

UNCY37378.0%

Gross Margin (TTM)

FHTX0.0%

UNCY0.0%

Operating Margin (TTM)

FHTX0.0%

UNCY0.0%

EBITDA Margin (TTM)

FHTX-180.6%

UNCY0.0%

Net Margin (TTM)

FHTX-175.8%

UNCY0.0%

FCF Margin (TTM)

FHTX-229.4%

UNCYN/A

Net Income (TTM)

FHTX$-65M

UNCY$-35M

FCF (TTM)

FHTX$-84M

UNCY$-28M

EPS (TTM)

FHTX-$0.91

UNCY-$1.31

ROE (TTM)

FHTX-30161.0%

UNCY-8881.0%

ROA (TTM)

FHTX-3117.0%

UNCY-5966.0%

ROIC (TTM)

FHTX-30161.0%

UNCY-8881.0%

Cash

FHTX$68M

UNCY$44M

Debt

FHTX$0

UNCY$0

Net Cash/Debt

FHTX$68M

UNCY$44M

Current Ratio (TTM)

FHTX3.36x

UNCY3.81x

Quick Ratio (TTM)

FHTX3.31x

UNCY3.28x

Debt/Equity (TTM)

FHTX0.00x

UNCY0.00x

Debt/Assets (TTM)

FHTX0.0%

UNCY0.0%

Interest Coverage (TTM)

FHTXN/A

UNCYN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

UNCY0.00x

Beta

FHTX3.13

UNCY1.78

52W Performance

FHTX-55.6%

UNCY-13.8%

YTD Performance

FHTX-61.5%

UNCY-29.1%

% from 52W High

FHTX-73.7%

UNCY-53.0%

% from 52W Low

FHTX11.7%

UNCY4.6%

Asset Turnover (TTM)

FHTX0.18x

UNCY0.05x

FCF Yield (TTM)

FHTX-71.8%

UNCY-25.4%

Earnings Yield (TTM)

FHTX-55.0%

UNCY-32.1%

Dividend Yield (TTM)

FHTXN/A

UNCYN/A

Rule of 40

FHTX-177.4

UNCY0.0

EV/GP/RG

FHTXN/A

UNCYN/A

Ticker research

View FHTX research View UNCY research

Metric	FHTX Foghorn Therapeutics Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$117M	$110M
Enterprise Value	$49M	$66M
Price	$2.00	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	31.15x
EV/Sales	1.34x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	0.31x
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	52.0%	N/A
Forward Rev Growth	7.3%	37378.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	0.0%
Net Margin (TTM)	-175.8%	0.0%
FCF Margin (TTM)	-229.4%	N/A
Net Income (TTM)	$-65M	$-35M
FCF (TTM)	$-84M	$-28M
EPS (TTM)	-$0.91	-$1.31
ROE (TTM)	-30161.0%	-8881.0%
ROA (TTM)	-3117.0%	-5966.0%
ROIC (TTM)	-30161.0%	-8881.0%
Financial Health
Cash	$68M	$44M
Debt	$0	$0
Net Cash/Debt	$68M	$44M
Current Ratio (TTM)	3.36x	3.81x
Quick Ratio (TTM)	3.31x	3.28x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	1.78
52W Performance	-55.6%	-13.8%
YTD Performance	-61.5%	-29.1%
% from 52W High	-73.7%	-53.0%
% from 52W Low	11.7%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.05x
FCF Yield (TTM)	-71.8%	-25.4%
Earnings Yield (TTM)	-55.0%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View UNCY research

Valuation

P/S Ratio

FHTX

3.20x

UNCY

31.15x

EV/FCF

UNCY

-2.35x

FHTX

-0.59x

Growth & revenue

Revenue Growth TTM

FHTX

52.0%

Forward Revenue Growth

UNCY

37378.0%

FHTX

7.3%

Profitability & performance

Gross Margin

FHTX

0.0%

UNCY

0.0%

ROE

UNCY

-8881.0%

FHTX

-30161.0%

FCF Yield %

UNCY

-25.4%

FHTX

-71.8%

52-Week Performance

UNCY

-13.8%

FHTX

-55.6%

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

FHTX$117M

UNCY$110M

Enterprise Value

FHTX$49M

UNCY$66M

Price

FHTX$2.00

UNCY$4.11

P/E Ratio

FHTXN/A

UNCYN/A

P/S Ratio

FHTX3.20x

UNCY31.15x

EV/Sales

FHTX1.34x

UNCY0.00x

EV/EBITDA

FHTX0.00x

UNCY0.00x

P/B Ratio

FHTX1,199.58x

UNCY2.21x

P/FCF Ratio

FHTXN/A

UNCYN/A

EV/FCF

FHTX-0.59x

UNCY-2.35x

PEG Ratio

FHTXN/A

UNCYN/A

Forward P/E (NTM)

FHTXN/A

UNCYN/A

Forward P/S (NTM)

FHTX4.04x

UNCY0.31x

Revenue (TTM)

FHTX$37M

UNCY$0

Revenue Growth (YoY)

FHTX52.0%

UNCYN/A

Forward Rev Growth

FHTX7.3%

UNCY37378.0%

Gross Margin (TTM)

FHTX0.0%

UNCY0.0%

Operating Margin (TTM)

FHTX0.0%

UNCY0.0%

EBITDA Margin (TTM)

FHTX-180.6%

UNCY0.0%

Net Margin (TTM)

FHTX-175.8%

UNCY0.0%

FCF Margin (TTM)

FHTX-229.4%

UNCYN/A

Net Income (TTM)

FHTX$-65M

UNCY$-35M

FCF (TTM)

FHTX$-84M

UNCY$-28M

EPS (TTM)

FHTX-$0.91

UNCY-$1.31

ROE (TTM)

FHTX-30161.0%

UNCY-8881.0%

ROA (TTM)

FHTX-3117.0%

UNCY-5966.0%

ROIC (TTM)

FHTX-30161.0%

UNCY-8881.0%

Cash

FHTX$68M

UNCY$44M

Debt

FHTX$0

UNCY$0

Net Cash/Debt

FHTX$68M

UNCY$44M

Current Ratio (TTM)

FHTX3.36x

UNCY3.81x

Quick Ratio (TTM)

FHTX3.31x

UNCY3.28x

Debt/Equity (TTM)

FHTX0.00x

UNCY0.00x

Debt/Assets (TTM)

FHTX0.0%

UNCY0.0%

Interest Coverage (TTM)

FHTXN/A

UNCYN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

UNCY0.00x

Beta

FHTX3.13

UNCY1.78

52W Performance

FHTX-55.6%

UNCY-13.8%

YTD Performance

FHTX-61.5%

UNCY-29.1%

% from 52W High

FHTX-73.7%

UNCY-53.0%

% from 52W Low

FHTX11.7%

UNCY4.6%

Asset Turnover (TTM)

FHTX0.18x

UNCY0.05x

FCF Yield (TTM)

FHTX-71.8%

UNCY-25.4%

Earnings Yield (TTM)

FHTX-55.0%

UNCY-32.1%

Dividend Yield (TTM)

FHTXN/A

UNCYN/A

Rule of 40

FHTX-177.4

UNCY0.0

EV/GP/RG

FHTXN/A

UNCYN/A

Ticker research

View FHTX research View UNCY research

Metric	FHTX Foghorn Therapeutics Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$117M	$110M
Enterprise Value	$49M	$66M
Price	$2.00	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	31.15x
EV/Sales	1.34x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	0.31x
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	52.0%	N/A
Forward Rev Growth	7.3%	37378.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	0.0%
Net Margin (TTM)	-175.8%	0.0%
FCF Margin (TTM)	-229.4%	N/A
Net Income (TTM)	$-65M	$-35M
FCF (TTM)	$-84M	$-28M
EPS (TTM)	-$0.91	-$1.31
ROE (TTM)	-30161.0%	-8881.0%
ROA (TTM)	-3117.0%	-5966.0%
ROIC (TTM)	-30161.0%	-8881.0%
Financial Health
Cash	$68M	$44M
Debt	$0	$0
Net Cash/Debt	$68M	$44M
Current Ratio (TTM)	3.36x	3.81x
Quick Ratio (TTM)	3.31x	3.28x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	1.78
52W Performance	-55.6%	-13.8%
YTD Performance	-61.5%	-29.1%
% from 52W High	-73.7%	-53.0%
% from 52W Low	11.7%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.05x
FCF Yield (TTM)	-71.8%	-25.4%
Earnings Yield (TTM)	-55.0%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View UNCY research